LRRK2 and Parkinson disease: Moreover, LRRK2 overexpression significantly accelerated the progression of α-syn aggregation in PD-related A53T SNCA transgenic mice, whereas the genetic ablation of LRRK2 was able to delay it (Lin et al., 2009).